GMED
Globus Medical
73.80$
-3.5%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.2% | 17.0% | 8.6% | 8.6% | 32.5% | 32.0% | 29.6% | 10.4% | 32.5% | 30.1% | 26.6% | 26.6% | 28.9% | |
| 9.7% | 11.5% | 9.1% | 10.1% | 10.7% | 10.4% | 11.0% | 9.5% | 9.2% | 8.5% | 9.2% | 8.8% | 8.9% | |
| 5.9% | 2.0% | 2.8% | 2.0% | 2.0% | 1.8% | 2.2% | 1.8% | 1.5% | 1.4% | 1.7% | 1.7% | 1.6% | |
| 3.6% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.4% | -7.4% | -7.0% | -18.6% | 5.6% | 4.1% | 1.6% | -7.6% | 0.2% | -4.5% | -3.7% | -7.0% | -3.8% | |
| 5.6% | 3.7% | 4.7% | 4.4% | 6.7% | 2.6% | 6.9% | 6.9% | 4.0% | 6.8% | 5.2% | 4.2% | 5.1% | |
| -21.1% | 52.0% | -7.7% | -1.6% | -2.4% | -15.8% | 22.0% | -40.1% | -9.9% | -13.5% | -24.0% | -16.3% | -15.9% | |
| 0.0% | -36.6% | -13.7% | -0.2% | 0.0% | -0.2% | -31.8% | -3.4% | -5.2% | -5.4% | 0.0% | -17.2% | -7.0% | |
| – | – | – | – | – | – | -75.2% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| 0.4% | -38.5% | -19.1% | 1.4% | 3.1% | 9.1% | -106.2% | -3.3% | -4.2% | 1.6% | 2.4% | -17.0% | -4.3% | |
| -7.0% | 30.4% | -18.7% | 9.0% | 33.9% | 24.6% | -54.0% | -31.1% | 18.5% | 18.7% | 4.6% | -6.7% | 8.8% | |
| 7.5% | 13.3% | 3.9% | 4.2% | 25.8% | 29.4% | 22.8% | 3.5% | 28.5% | 23.3% | 21.4% | 22.4% | 23.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.